Triggered milestone payments disclosed by biopharma companies, including:Aduro, Alvogen Korea, Arecor, Basilea, Bristol-Myers Squibb, Cytomx, Eurofarma Laboratórios, Merck & Co., Molecular Templates, Oncodesign, Pfizer, Servier, Summit, Takeda, Vivus.